Rejected
at 5:09 a.m. Dec, 26, 2023 ]
by
herstein.jacob
Author:
Eli.Tanenbaum
Rationale for change
M
Current
Suggested
Extra
Extra
Extra
Extra
Text
Medications shown to improve long-term survival in patients with LV systolic dysfunction include:
1. {{c1::β-blockers}}
2. {{c1::ACEIs (or ARBs)}}
3. {{c1::Sacubitril-valsartan (ARNIs)}}
4. {{c1::Mineralocorticoid receptor antagonists (MRAs)}}
5. {{c1::SGLT-2 inhibitors}}
6. {{c1::Hydralazine}} with {{c1::isosorbide dinitrate}} in African American patients
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy



Watch Beta Blockers




Watch Sacubitril-Valsartan, Milrinone, Nesiritide, Ivabradine



Watch K+ Sparing Diuretics







Watch Primary Hypertension & Hypertensive Emergency



Watch Beta Blockers




Watch Sacubitril-Valsartan, Milrinone, Nesiritide, Ivabradine



Watch K+ Sparing Diuretics








Sketchy 2







Watch Chronic Heart Failure Management Part 1




Watch Chronic Heart Failure Management Part 2




Watch Diabetes Management




Watch Hypertension Management



Watch Post-ACS Management







Watch Chronic Heart Failure Management Part 1




Watch Chronic Heart Failure Management Part 2




Watch Diabetes Management




Watch Hypertension Management



Watch Post-ACS Management
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources

Emma Holiday:

Emma Holiday:

One by one
Empty field










